Julien Marie

PhD & HDR — Immunology · Ecole Normale Supérieure de Lyon · Inserm

Professor · Deputy Director, CRCL Lyon · Director of Research DR1, Inserm

PhD in Immuno-virology from the Ecole Normale Supérieure de Lyon (1999–2002); Habilitation à Diriger des Recherches (HDR, 2009). Deputy Director of the Cancer Research Centre of Lyon (CRCL, since 2024) and Director of Research DR1 at Inserm (since 2013). Head of the TGF-β and Immune Regulation laboratory at the CRCL. Invited to the Nobel Prize Laureates Meeting (Lindau, Germany, 2007). ERC Starting Grant laureate (€1.5M), Bettencourt-Schueller Foundation Prize (2011), SANOFI European I Award for translational research (2019), Academy of Sciences Dandrimont-Benicourt Prize (2024). Scientific advisor to Allogenica, Morphix, and Lilly; member of the ImCore Roche-Genentech board. Over 90 invited lectures at international meetings; 4 patents filed including one with Sanofi. His research focuses on TGF-β signalling, TH17/Treg cell biology, and immune evasion mechanisms in cancer and autoimmune disease.

Cancer Research Centre of Lyon (CRCL) · Inserm

Rufin VanRullen

PhD — Cognitive Science & Computational Neuroscience · Université Paul Sabatier, Toulouse

Research Director (DR1), CNRS · AI Research Chair, ANITI

PhD in Cognitive Science from Université Paul Sabatier, Toulouse (2000). CNRS Research Director (DR1) at the Centre de Recherche Cerveau et Cognition (CerCo) and AI Research Chair at ANITI, Toulouse. Former Visiting Scholar at the Harvard Vision Sciences Lab (2005–2007). 128 peer-reviewed publications, h-index 51, over 13,300 citations. ERC Consolidator Grant laureate (€1.86M), European Young Investigator (EURYI) Award (2007), and CNRS Bronze Medal (2007). Scientific Advisory Board member of Brainchip Inc (USA) and the BIAL Foundation (Portugal). Pioneering research at the intersection of computational neuroscience and artificial intelligence — neural oscillations, visual perception, and predictive coding.

Centre de Recherche Cerveau et Cognition (CerCo) · ANITI, Toulouse

Aimen Zerroug

PhD — Artificial Intelligence & Neurosciences · ANITI · CentraleSupélec

Co-Founder & President, iDISCOVR · AI Engineer

Engineering degree from CentraleSupélec, Gif-sur-Yvette (2019), specialising in Computer Systems. PhD in Artificial Intelligence and Neurosciences at ANITI (2019–2023), conducted in partnership with EDF R&D — focusing on bio-inspired neural networks, generative AI, logical reasoning, and efficient learning. Prior research experience at Dassault Systèmes (AI for 3D model generation). Co-founder and President of iDISCOVR. His doctoral work bridges machine learning and computational neuroscience. He brings technical depth to AI strategy, architecture review, and technical due diligence of AI and immersive technology assets.

iDISCOVR · CentraleSupélec · ANITI · EDF R&D

Fabien Thollot

Executive MBA

European Patent Attorney · YesMyPatent · Founder, Angel Corp & Bonsoir Entertainment

European Patent Attorney and founder of YesMyPatent, Angel Corp, and Bonsoir Entertainment. He practises patent law with a focus on life sciences, biotech, software, and creative industry assets — including freedom-to-operate analyses, prior art searches, and licensing strategy. His Executive MBA complements his technical training, enabling him to bridge IP protection, valuation, and commercial strategy for innovation-intensive clients.

Ramdane Igalouzene

PhD — Immunology & Cancer Biology · Université Lyon 1 · CRCL

Co-Founder & CEO, iDISCOVR · Immunologist · Scientific & Strategic Advisor

PhD in Immunology and Cancer Biology from Université Lyon 1 / Cancer Research Centre of Lyon (CRCL, Prof. Julien Marie's laboratory, 2017–2021). Co-founder and CEO of iDISCOVR. Laureate of the French Ministry doctoral fellowship (€100K, 2017–2021) and ARC Foundation research grant (€30K, 2020–2021). Best oral communication award, BMIC doctoral school, Lyon (2019). International presenter at the Keystone Tissue Immunity Symposium (Boulder, Colorado, 2020). His work spans the scientific validation of immersive experiences, cross-functional leadership, and the intersection of biological science and advanced technologies. He brings experience in biotech strategy, scientific storytelling, and business development to complex advisory mandates.

iDISCOVR · Cancer Research Centre of Lyon (CRCL)

Taha Zemmouri

MSc Data Science & Big Data

CEO & Co-Founder, Eden AI

CEO and co-founder of Eden AI, an AI gateway platform providing unified API access to over 100 AI models from leading providers including OpenAI, Google, and AWS. Trained as a Data Science and Big Data engineer at École des Mines de Saint-Étienne and emlyon business school, he built experience in AI consulting before founding Eden AI in Lyon in 2021. Under his leadership the platform raised €3M and serves developers and enterprises seeking to integrate, compare, and orchestrate AI capabilities at scale. He brings strategic and operational depth to AI adoption roadmaps, model selection, and AI infrastructure assessment.

École des Mines de Saint-Étienne · emlyon business school

Mohamed Kadem

Pharm.D. · Master 2 PIF2P — Pharmaceutical Industrialization · Université Grenoble Alpes / INP / GEM

Senior Transition Manager & Independent Validation Expert

Doctor of Pharmacy (Pharm.D., Université Ferhat Abbas, 2012) and Master 2 in Pharmaceutical Industrialization, Formulation, Processes and Production (PIF2P) — a joint programme of Université Grenoble Alpes, Institut Polytechnique de Grenoble (INP), and Grenoble Ecole de Management (2015–2016). Senior transition manager and independent expert in pharmaceutical validation and industrialization, with over 10 years of field experience at Eli Lilly, Skyepharma, Sanofi Pasteur, bioMérieux, LFB, and Galderma. Lecturer at the Master 2 PIF2P programme, Université Grenoble Alpes (since 2019). Co-author of the A3P Scientific & Technical Guide n°6 (2025): Operational Guidance on Continued Process Verification (CPV). Member of the GIC-CPV working group, Association A3P (since 2022). His expertise covers GMP compliance, ASTM E2500 verification methodology, tech transfer, process validation, CPV, metrology, and C&Q protocols for complex pharmaceutical manufacturing.

Université Grenoble Alpes · Institut Polytechnique de Grenoble · Grenoble Ecole de Management

Saidi Soudja

PhD · HDR — Immunology · CIML Marseille · Université Lyon 1

Group Lead "HomeoShape", CIRI INSERM U1111-CNRS UMR5308

PhD in Immunology from the Centre d'Immunologie de Marseille-Luminy (CIML, 2005–2009); Habilitation à Diriger des Recherches (HDR, Université Lyon 1, 2023). Group Lead of the "HomeoShape" group at CIRI (INSERM U1111–CNRS UMR5308, team GIMAP, since 2024). Former post-doctoral fellow at Albert Einstein College of Medicine, New York (2009–2014, Dr. Grégoire Lauvau's laboratory). Prix Dennis Shield, Albert Einstein College of Medicine (2012). Prix Fondation UJM (2024). ANR grant coordinator (2022). His laboratory investigates mucosal and intestinal immunity, cytotoxic lymphocytes (NK and CD8 T cells), host-microbiota interactions, and cancer immunology — with a focus on the mechanisms of immune homeostasis in intestinal pathology and host protection against infection.

CIRI INSERM U1111-CNRS UMR5308 · Albert Einstein College of Medicine · CIML Marseille